KLK3 and prostate carcinoma: The mean prostate-specific antigen was lower in metformin users with DM (mean ± standard deviation: 5.4 ± 2.1) than in non-users with unspecified DM conditions (mean ± standard deviation: 9.2 ± 7.9) of prostate cancer [35].